Patents by Inventor Carlos Escande

Carlos Escande has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nitroalkene trolox derivatives and methods of use thereof in the treatment and prevention of inflammation related conditions
    Patent number: 9994541
    Abstract: The present invention is directed to a class of anti-inflammatory, antioxidant nitroalkene compounds used in biological or biochemical applications to reduce oxidative stress or damage. The nitroalkene compounds described herein further avoid disadvantageous metabolism currently present in this field.
    Type: Grant
    Filed: August 23, 2016
    Date of Patent: June 12, 2018
    Inventors: Carlos Batthyány, Gloria Virginia López, Rosina Dapueto, Carlos Escande, Jorge Rodriguez Duarte
  • Methods of Treatment of inflammation related conditions using pluripotent anti-inflammatory and metabolic Modulators
    Publication number: 20180104202
    Abstract: Methods of treating acute and chronic inflammatory conditions, tissue transplant rejection, and/or organ transplant rejection comprising administering to a subject in need thereof a therapeutically effective amount of a pluripotent anti-inflammatory and metabolic modulators optionally in combination with one or more secondary therapeutic agents and pharmaceutical compositions thereof.
    Type: Application
    Filed: October 16, 2017
    Publication date: April 19, 2018
    Applicants: Institut Pasteur de Montevideo, Universidad de la República
    Inventors: Carlos Batthyány, Gloria Virginia López, Carlos Escande, Jorge Rodriguez Duarte, Williams Arturo Porcal Quinta, Rosina Dapueto Capuccio, Germán Adrian Galliussi López, María Pia Garat Nuñez, Marcelo Hill, Mercedes Segovia
  • Nitroalkene Trolox Derivatives and Methods of Use Thereof In The Treatment And Prevention of Inflammation Related Conditions
    Publication number: 20180057475
    Abstract: The present invention is directed to a class of anti-inflammatory, antioxidant nitroalkene compounds used in biological or biochemical applications to reduce oxidative stress or damage. The nitroalkene compounds described herein further avoid disadvantageous metabolism currently present in this field.
    Type: Application
    Filed: August 23, 2016
    Publication date: March 1, 2018
    Applicant: Institut Pasteur de Montevideo
    Inventors: Carlos Batthyány, Gloria Virginia López, Rosina Dapueto, Carlos Escande, Jorge Rodriguez Duarte